)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Executives say move unlikely to affect prices of IVF procedures
Mercedes-Benz India expects record sales in 2026, banking on robust demand and a healthy order pipeline despite further price hikes driven by the appreciation of the euro
India's EV market crossed 12 per cent of overall vehicle retail sales for the first time in June, driven by record electric two-wheeler sales and broad-based growth across segments
Anand Mahindra says India is well placed to bridge geopolitical blocs, while Group CEO Anish Shah says artificial intelligence will power the conglomerate's next phase of growth
Hospitals across Mumbai have maintained routine medical services despite heavy rains, but doctors report rising seasonal illnesses and slower ambulance movement due to waterlogging
Suzuki Motor Corporation will expand the capacity of its newly inaugurated Kharkhoda manufacturing facility in phases, reinforcing its long-term commitment to India
Harrier EV demand is nearly double current production capacity as Tata Motors targets monthly output of 70,000 vehicles with expanded manufacturing and supplier ramp-up
Chairman N Chandrasekaran says the combined Tata Motors-Iveco business could lift annual revenue to $35-40 billion in five years, boosting global scale and technology
Demand for GLP-1 drugs such as semaglutide is exposing capacity gaps across peptide APIs, sterile fill-finish facilities, injector devices and glass cartridges
Following the completion of the transaction, Pivot Path will be reclassified from a wholly owned subsidiary to an associate company of Strides
Commercial vehicle wholesales rose 13.5 per cent in May, supported by GST cuts and a favourable base, but ICRA expects growth to moderate to 4-6 per cent in FY27
The joint venture will invest over $20 million in a pharmaceutical manufacturing facility in Sri Lanka to boost local drug production and reduce reliance on imports
USFDA completed a pre-license inspection of the Hyderabad facility and issued a Form 483 with seven observations, which the company said it will address within the stipulated timeline
Tata Motors says commercial vehicle electrification is nearing a tipping point, driven by improving economics, localisation and policy support
Tata Motors to begin pilot trials of trucks running on 2% isobutanol-blended diesel next quarter as India explores alternative fuels to cut oil imports
Biocon, Zydus, Dr Reddy's are among companies positioning for one of the largest biosimilar launches for cancer treatment
The drugmaker said it is monitoring its systems and maintaining normal operations after reports that a hacking group claimed to have stolen and published company data
The hospital chain said its planned public listing remains the preferred route even as parent company Medicover AB holds preliminary discussions with KKR
Electric two-wheeler makers are expanding capacity as rising demand and model-specific shortages lead to longer delivery timelines in several markets
Indian drugmakers are reducing reliance on US generics, turning to specialty medicines, biosimilars and emerging markets to drive sustainable growth